[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"velocardiofacial-syndrome\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:velocardiofacial-syndrome":46},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":10,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":21,"briefSummary":23,"conditions":24,"keywords":28,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":41,"leadSponsor":43,"locationsCount":5},"100115485",false,"NCT00768820","The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome","The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome (VCFS), Williams Syndrome (WS)and Fragile X Syndrome Characterization, Treatment and Examining the Connection to Developmental and Molecular Factors","VCFS","Inclusion Criteria:\n\n* chromosomal deletion proven by FISH examination\n\nExclusion Criteria:","ALL",{"count":18,"type":19},400,"ESTIMATED","INTERVENTIONAL",[22],"PHASE4","The purpose of this study is to investigate the Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome (VCFS), Williams Syndrome (WS)and Fragile X Syndrome Characterization, Treatment and Examining the Connection to Developmental and Molecular Factors",[25,26,27],"Velocardiofacial Syndrome","Williams Syndrome","Fragile X Syndrome",[29,30,31,32,33],"Velocardiofacial syndrome","Williams syndrome","fragile X syndrome","cognitive phenotype","psychiatric phenotype","RECRUITING","2026-03-17",{"date":37,"type":38},"2026-03-18","ACTUAL",{"date":40,"type":4},"2001-05",{"date":42,"type":19},"2027-08",{"name":44,"class":45},"The Chaim Sheba Medical Center","OTHER",""]